The mechanism is attributed to the ability of ginsenoside Rg3 to reduce the nuclear localisation of HIF-1α and inhibit the evolution of EMT-related pulmonary fibrosis mediated by the TGF-β1/Smad3 signalling pathway. Here, HIF1A is linked to pulmonary fibrosis.